Clincosm LogoSign in Get a demo

neoadjuvant chemotherapy

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

Not yet recruiting
  • Organoids
  • +2 more
  • Biopsy
  • (no location specified)
Nov 24, 2023

Breast Cancer Patients

Completed
  • Neoadjuvant Chemotherapy
  • Neoadjuvant therapy
  • Istanbul, Turkey
    AcıbademAH
Nov 21, 2023

Micrometastases in Axillary Lymph Nodes in Breast Cancer,

Completed
  • Micrometastases
  • Neoadjuvant Chemotherapy
  • Sentinel lymph node biopsy, axillary lymph node dissection
  • (no location specified)
Nov 20, 2023

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Gastric Cancer, Neoadjuvant Chemo Trial in Qingdao (live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules)

Recruiting
  • Gastric Cancer
  • Neoadjuvant Chemotherapy
  • live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
  • Qingdao, Shandong, China
    Department of Gastrointestinal Surgery, Qingdao University Affil
Jun 4, 2023

DLCS for Predicting Neoadjuvant Chemotherapy Response

Recruiting
  • Gastric Cancer
  • +4 more
  • develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022

Neoadjuvant Chemo, PD-1 Antibody, Radiotherapy Trial (neoadjuvant chemo combined with PD-1 antibody + radical radiotherapy)

Not yet recruiting
  • Neoadjuvant Chemotherapy
  • +3 more
  • neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy
  • (no location specified)
Sep 21, 2022

Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Netherlands (Fasting

Not yet recruiting
  • Fasting Mimicking Diet
  • +5 more
  • Fasting Mimicking diet program
  • Alkmaar, Netherlands
  • +14 more
Aug 15, 2022

Cervical Cancer, Neoadjuvant Chemo, Bulky Tumor Trial in Guangzhou (Albumin-Bound Paclitaxel, Carboplatin)

Recruiting
  • Cervical Cancer
  • +2 more
  • Guangzhou, Guangdone, China
    Sun Yat-sen University Cancer Center
May 9, 2022

Rectal Cancer, Neoadjuvant Chemo Trial in Wuxi, Chengdu, Kunming (Capox chemo)

Recruiting
  • Rectal Cancer
  • Neoadjuvant Chemotherapy
  • Capox chemotherapy
  • Wuxi, Jiangsu, China
  • +3 more
Mar 16, 2022

Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

Recruiting
  • Hyperthermic Intraperitoneal Chemotherapy
  • Neoadjuvant Chemotherapy
  • HIPEC
  • intravenous chemotherapy
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Feb 17, 2022

Muscle Invasive Bladder Cancer, Urothelial Carcinoma, Neoadjuvant Chemo Trial in Yangsan (dose dense MVAC with pegylated GCSF)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +2 more
  • dose dense MVAC with pegylated GCSF
  • Yangsan, Gyeongsangnam-do, Korea, Republic of
    Pusan National University Yangsan Hospital
Feb 2, 2022

Cervical Cancer, Neoadjuvant Chemo Trial in Shantou (gemcitabine and cisplatin)

Recruiting
  • Cervical Cancer
  • Neoadjuvant Chemotherapy
  • gemcitabine and cisplatin
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Jan 18, 2022

Colorectal Cancer, Neoadjuvant Chemo, Stent Trial in Beijing (Immunotherapy (Camrelizumab))

Recruiting
  • Colorectal Cancer
  • +4 more
  • Immunotherapy (Camrelizumab)
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
Jan 10, 2022

Ovarian Cancer, Neoadjuvant Chemo, Prehabilitation Trial in Chicago (FIT4SURGERY, Healthy Lifestyle Control)

Recruiting
  • Ovarian Cancer
  • +2 more
  • FIT4SURGERY
  • Healthy Lifestyle Control
  • Chicago, Illinois
    Northwestern University
Jan 4, 2022

High-risk Locally Advanced Colorectal Cancer, Neoadjuvant Chemo, FOLFOXIRI Regimen Trial in Chengdu (Oxaliplatin, Irinotecan,

Recruiting
  • High-risk Locally Advanced Colorectal Cancer
  • +2 more
  • Chengdu, Sichuan, China
    Sichuan University West China Hospital
Aug 18, 2021

HER2-negative Breast Cancer, Neoadjuvant Chemo Trial in Hangzhou (Epirubicin, Cyclophosphamid, Docetaxel)

Recruiting
  • HER2-negative Breast Cancer
  • Neoadjuvant Chemotherapy
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 9, 2021

Epithelial Carcinoma, Ovarian, Neoadjuvant Chemo Trial in Chendu (cisplatin i.p.)

Recruiting
  • Epithelial Carcinoma, Ovarian
  • Neoadjuvant Chemotherapy
  • cisplatin i.p.
  • Chendu, Sichuan, China
    West China Second University Hospital of Sichuan University
Aug 3, 2021

Breast Cancer, Sentinel Lymph Node Biopsy, Neoadjuvant Chemo Trial in Rijeka

Enrolling by invitation
  • Breast Cancer
  • +2 more
    • Rijeka, Croatia
      Ana Car Peterko
    Aug 2, 2021

    Gastric Cancer, Neoadjuvant Chemo Trial in Shanghai (Chemotherapy)

    Not yet recruiting
    • Gastric Cancer
    • Neoadjuvant Chemotherapy
    • Shanghai, Shanghai, China
      Ruijin Hospital Shanghai Jiaotong University School of Medicine
    Jul 15, 2021

    Gastric Cancer, Magnetic Resonance Imaging, Tomography, X-Ray Computed Trial (PD-1 inhibitor)

    Not yet recruiting
    • Gastric Cancer
    • +4 more
    • PD-1 inhibitor
    • (no location specified)
    May 30, 2021

    Ovarian Cancer, Neoadjuvant Chemo, Anti-PD-1 Trial in Hangzhou (BGB-A317, albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5)

    Recruiting
    • Ovarian Cancer
    • +3 more
    • BGB-A317
    • albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital of Zhejiang University School of Medi
    Mar 23, 2021

    Adenocarcinoma of Esophagogastric Junction, Neoadjuvant Chemo, Pembrolizumab Trial in Tianjin (Pembrolizumab Injection

    Recruiting
    • Adenocarcinoma of Esophagogastric Junction
    • +2 more
    • Pembrolizumab Injection [Keytruda]
    • Tianjin, Tianjin, China
      Department of minimally invasive esophageal surgery, Tianjin Med
    Mar 22, 2021

    Colorectal Cancer, Neoadjuvant Chemo, Stent Trial in China (Stenting with neoadjuvant chemo, Stenting with immediate Surgery)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Stenting with neoadjuvant chemotherapy
    • Stenting with immediate Surgery
    • Beijing, Beijing, China
    • +31 more
    Feb 4, 2021